214 related articles for article (PubMed ID: 11430505)
1. Gastro-oesophageal reflux disease and Helicobacter pylori or gastro-oesophageal reflux disease from Helicobacter pylori?
Lundell L
Eur J Gastroenterol Hepatol; 2001 May; 13 Suppl 1():S23-7. PubMed ID: 11430505
[TBL] [Abstract][Full Text] [Related]
2. Review article: Helicobacter pylori and gastro-oesophageal reflux disease.
Delaney B; McColl K
Aliment Pharmacol Ther; 2005 Aug; 22 Suppl 1():32-40. PubMed ID: 16042657
[TBL] [Abstract][Full Text] [Related]
3. Should Helicobacter pylori be eradicated before starting long-term proton pump inhibitors?
Rauws EA
Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):569-73. PubMed ID: 9513835
[TBL] [Abstract][Full Text] [Related]
4. Helicobacter pylori infection and gastro-oesophageal reflux disease: coincidence or association?
Malfertheiner P; Gerards C
Baillieres Best Pract Res Clin Gastroenterol; 2000 Oct; 14(5):731-41. PubMed ID: 11003806
[TBL] [Abstract][Full Text] [Related]
5. Helicobacter pylori and gastroesophageal reflux disease: friends or foes?
Gisbert JP; Pajares JM; Losa C
Hepatogastroenterology; 1999; 46(26):1023-9. PubMed ID: 10370661
[TBL] [Abstract][Full Text] [Related]
6. Helicobacter pylori infection influences symptomatic response to anti-secretory therapy in patients with GORD--crossover comparative study with famotidine and low-dose lansoprazole.
Adachi K; Hashimoto T; Komazawa Y; Mihara T; Furuta K; Fujishiro H; Ishihara S; Amano Y; Hattori S; Kinoshita Y
Dig Liver Dis; 2005 Jul; 37(7):485-90. PubMed ID: 15975534
[TBL] [Abstract][Full Text] [Related]
7. Helicobacter pylori, proton pump inhibitors and gastroesophageal reflux disease.
Kuipers EJ; Klinkenberg-Knol EC; Meuwissen SG
Yale J Biol Med; 1999; 72(2-3):211-8. PubMed ID: 10780583
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of treatment for gastro-oesophageal reflux disease with a proton pump inhibitor, and relationship between gastro-oesophageal reflux disease and Helicobacter pylori infection in Japan.
Muramatsu A; Azuma T; Okajima T; Ohtani M; Dojo M; Yamazaki Y; Kuriyama M
Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():102-6. PubMed ID: 15298614
[TBL] [Abstract][Full Text] [Related]
9. [Does H. pylori infection or its eradication play a role in gastroeosphageal reflux disease?].
Zerbib F
Gastroenterol Clin Biol; 2003 Mar; 27(3 Pt 2):427-31. PubMed ID: 12700499
[TBL] [Abstract][Full Text] [Related]
10. Treatment of gastro-oesophageal reflux disease with rabeprazole in primary and secondary care: does Helicobacter pylori infection affect proton pump inhibitor effectiveness?
Wit NJ; Boer WA; Geldof H; Hazelhoff B; Bergmans P; Tytgat GN; Smout AJ
Aliment Pharmacol Ther; 2004 Aug; 20(4):451-8. PubMed ID: 15298640
[TBL] [Abstract][Full Text] [Related]
11. Gastroesophageal reflux disease and Helicobacter pylori infection.
Vakil N
Rev Gastroenterol Disord; 2003; 3(1):1-7. PubMed ID: 12684588
[TBL] [Abstract][Full Text] [Related]
12. [Influence of Helicobacter pylori on gastroesophageal reflux disease].
Mieczysława CS; Monika P
Pol Merkur Lekarski; 2007 Dec; 23(138):449-53. PubMed ID: 18432130
[TBL] [Abstract][Full Text] [Related]
13. Chronic inactive gastritis and coccoid Helicobacter pylori in patients treated for gastroesophageal reflux disease or with H pylori eradication therapy.
Goldstein NS
Am J Clin Pathol; 2002 Nov; 118(5):719-26. PubMed ID: 12428792
[TBL] [Abstract][Full Text] [Related]
14. Review article: influence of Helicobacter pylori on gastro-oesophageal reflux disease in Japan.
Haruma K
Aliment Pharmacol Ther; 2004 Dec; 20 Suppl 8():40-4. PubMed ID: 15575872
[TBL] [Abstract][Full Text] [Related]
15. Consequences of long-term proton pump blockade: insights from studies of patients with gastrinomas.
Jensen RT
Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):4-19. PubMed ID: 16433886
[TBL] [Abstract][Full Text] [Related]
16. Interleukin 1B proinflammatory genotypes protect against gastro-oesophageal reflux disease through induction of corpus atrophy.
Ando T; El-Omar EM; Goto Y; Nobata K; Watanabe O; Maeda O; Ishiguro K; Minami M; Hamajima N; Goto H
Gut; 2006 Feb; 55(2):158-64. PubMed ID: 16120761
[TBL] [Abstract][Full Text] [Related]
17. Famotidine vs. omeprazole: a prospective randomized multicentre trial to determine efficacy in non-erosive gastro-oesophageal reflux disease.
Fujiwara Y; Higuchi K; Nebiki H; Chono S; Uno H; Kitada K; Satoh H; Nakagawa K; Kobayashi K; Tominaga K; Watanabe T; Oshitani N; Arakawa T
Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():10-8. PubMed ID: 15943841
[TBL] [Abstract][Full Text] [Related]
18. Gastro-oesophageal reflux and Helicobacter pylori.
Pace F; Bianchi Porro G
Ital J Gastroenterol Hepatol; 1998 Oct; 30 Suppl 3():S289-93. PubMed ID: 10077757
[TBL] [Abstract][Full Text] [Related]
19. The possible role of Helicobacter pylori in GERD.
Falk GW
Semin Gastrointest Dis; 2001 Jul; 12(3):186-95. PubMed ID: 11478751
[TBL] [Abstract][Full Text] [Related]
20. Pathogenesis of gastro-oesophageal reflux disease: what role do Helicobacter pylori and host genetic factors play?
Chourasia D; Ghoshal UC
Trop Gastroenterol; 2008; 29(1):13-9. PubMed ID: 18564661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
